GTO ID | GTC3719 |
Trial ID | NCT06208878 |
Disease | Hematological Malignancy |
Therapy | CAR-T cell |
Treatment | CRISPR CAR T cells |
Recruitment status | Enrolling By Invitation |
Title | A Long-term Follow-up Study of Subjects With Malignancies Treated With CRISPR CAR T Cellular Therapies |
Year | 2023 |
Country | United States |
Company sponsor | CRISPR Therapeutics AG |
Other ID(s) | CRSP-ONC-LTF |
Cohort 1 | |||||||
|